T cell subset | Controls (n = 19) | Cases (n = 19) | p-value* |
---|---|---|---|
CD4 T lymphocytes ± |  |  |  |
   CD4+ | 21.8 (17.2 – 32.5) | 21.0 (14.4 – 25.5) | 0.38 |
   CD27+ CD45RO- (N) | 10.5 (8.44 – 25.3) | 15.3 (3.07–25.8) | 0.90 |
   CD27+ CD45RO+ (CM) | 43.8 (31.3–55.7) | 30.8 (13.9 – 50.0) | 0.07 |
   CD27- CD45RO+ (EM) | 27 (13.2 – 42.8) | 40.8 (23.9 – 58.9) | 0.20 |
   CD57+ CD45RO- (TE) | 0.37 (0.1 – 1.4) | 0.38 (0.18 – 2.76) | 0.58 |
   CD57+ CD45RO+ (E) | 3.99 (1.94 – 10.7) | 6.03 (2.63 – 22) | 0.17 |
CD8 T lymphocytes ± |  |  |  |
   CD8+ | 70.2 (60.1 – 77) | 68.3 (60.5 – 77.4) | 0.90 |
   CD27+ CD45RO- (N) | 13.3 (9.9 – 17.9) | 18.5 (10.3 – 26.6) | 0.23 |
   CD27+ CD45RO+ (CM) | 13.9 (10.4 – 22.6) | 7.81 (3.46 – 12.7) | 0.01 |
   CD27- CD45RO+ (EM) | 29 (22.7 – 36.1) | 20.2 (9.0 – 31.7) | 0.08 |
   CD57+ CD45RO- (TE) | 15.1 (12.1 – 30.8) | 28.8 (18.0 – 42.0) | 0.05 |
   CD57+ CD45RO+ (E) | 13.2 (7.6 – 24.5) | 8.8 (5.5 – 10.7) | 0.04 |